Integrating scientific expertise and support for research, Artialis is able to manage every stage of drug development, from preclinical development to post-marketing clinical studies including personalized biomarker-based solutions to address unmet needs.
Artialis CRO is dedicated to musculoskeletal health and age-related disorders. Artialis is partner of choice for the development of therapeutic approaches (drug, medical device as well as food supplement) for biotech, pharma companies and food supplement/nutrition industry.
In vitro - In vivo studies - Imaging - Ex vivo testing (Biomarkers & Biomechanics) - Gold standards parameters - Proof of efficacy - Tailor-made studies
Trial design (first-in-man to phase IV) - Protocol writing - KOL & Scientific board - Innovative markers - Site selection & management - Recruitment tools – Data monitoring - Data management & Biostatistics - Final report - Scientific Writing
Imaging and soluble biomarkers centralized platform